📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Shape-based reprofiling of FDA-approved drugs for the H1 histamine receptor. (2012)

First Author: Vasudevan SR

Attributed to: Rational design and biological evaluation of cell-permeant small molecule agonists and antagonists of the NAADP receptor funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/jm300671m

PubMed Identifier: 22793499

Publication URI: http://europepmc.org/abstract/MED/22793499

Type: Journal Article/Review

Volume: 55

Parent Publication: Journal of medicinal chemistry

Issue: 16

ISSN: 0022-2623